The European Register of Cystic Echinococcosis, ERCE: state-of-the-art five years after its launch.


Journal

Parasites & vectors
ISSN: 1756-3305
Titre abrégé: Parasit Vectors
Pays: England
ID NLM: 101462774

Informations de publication

Date de publication:
07 May 2020
Historique:
received: 27 11 2019
accepted: 25 04 2020
entrez: 9 5 2020
pubmed: 10 5 2020
medline: 7 1 2021
Statut: epublish

Résumé

The real burden of human cystic echinococcosis (CE) remains elusive, due to the peculiar characteristics of the disease and the heterogeneous and incomplete data recording of clinical cases. Furthermore, official notification systems do not collect pivotal clinical information, which would allow the comparison of different treatment outcomes, and thus circumvent the difficulty of implementing clinical trials for CE. The Italian Register of CE (RIEC) was launched in 2012 and expanded in 2014 into the European Register of CE (ERCE). The primary aim of the ERCE was to highlight the magnitude of CE underreporting, through the recording of cases that were not captured by official records. We present an overview of data collated in the ERCE and discuss its future, five years after its inception. The ERCE database was explored on March 31st 2019; data concerning participating centres and registered cases were descriptively analysed. Forty-four centres from 15 countries (7 non-European) were affiliated to the ERCE. Thirty-four centres (77%) registered at least one patient; of these, 18 (53%) recorded at least one visit within the past 18 months. A total of 2097 patients were registered, 19.9% of whom were immigrants. Cyst characteristics were reported for at least one cyst at least in one visit in 1643 (78.3%) patients, and cyst staging was used by 27 centres. In total, 3386 cysts were recorded at first registration; mostly located in the liver (75.5%). Data concerning clinical management could be analysed for 920 "cyst stage-location-management" observations, showing great heterogeneity in the implementation of the stage-specific management approach recommended by the WHO. The ERCE achieved its goal in showing that CE is a relevant but neglected public health problem in Europe and beyond, since a proportion of patients reaching medical attention are not captured by official notification systems. The ERCE may provide a valuable starting platform to complement hospital-derived data, to obtain a better picture of the epidemiology of clinical CE, and to collect clinical data for the issue of evidence-based recommendations. The ERCE will be expanded into the International Register of CE (IRCE) and restructured aiming to overcome its current criticalities and fulfil these aims.

Sections du résumé

BACKGROUND BACKGROUND
The real burden of human cystic echinococcosis (CE) remains elusive, due to the peculiar characteristics of the disease and the heterogeneous and incomplete data recording of clinical cases. Furthermore, official notification systems do not collect pivotal clinical information, which would allow the comparison of different treatment outcomes, and thus circumvent the difficulty of implementing clinical trials for CE. The Italian Register of CE (RIEC) was launched in 2012 and expanded in 2014 into the European Register of CE (ERCE). The primary aim of the ERCE was to highlight the magnitude of CE underreporting, through the recording of cases that were not captured by official records. We present an overview of data collated in the ERCE and discuss its future, five years after its inception.
METHODS METHODS
The ERCE database was explored on March 31st 2019; data concerning participating centres and registered cases were descriptively analysed.
RESULTS RESULTS
Forty-four centres from 15 countries (7 non-European) were affiliated to the ERCE. Thirty-four centres (77%) registered at least one patient; of these, 18 (53%) recorded at least one visit within the past 18 months. A total of 2097 patients were registered, 19.9% of whom were immigrants. Cyst characteristics were reported for at least one cyst at least in one visit in 1643 (78.3%) patients, and cyst staging was used by 27 centres. In total, 3386 cysts were recorded at first registration; mostly located in the liver (75.5%). Data concerning clinical management could be analysed for 920 "cyst stage-location-management" observations, showing great heterogeneity in the implementation of the stage-specific management approach recommended by the WHO.
CONCLUSIONS CONCLUSIONS
The ERCE achieved its goal in showing that CE is a relevant but neglected public health problem in Europe and beyond, since a proportion of patients reaching medical attention are not captured by official notification systems. The ERCE may provide a valuable starting platform to complement hospital-derived data, to obtain a better picture of the epidemiology of clinical CE, and to collect clinical data for the issue of evidence-based recommendations. The ERCE will be expanded into the International Register of CE (IRCE) and restructured aiming to overcome its current criticalities and fulfil these aims.

Identifiants

pubmed: 32381109
doi: 10.1186/s13071-020-04101-6
pii: 10.1186/s13071-020-04101-6
pmc: PMC7206799
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

236

Subventions

Organisme : European platform EULAC-Health and the Italian Ministry of Health
ID : PERITAS project
Organisme : Seventh Framework Programme (Health), European Commission
ID : HERACLES project 602051

Investigateurs

A Angheben (A)
M Belhassen Garcia (M)
N Bagmet (N)
S Borys (S)
S Bresson-Hadni (S)
F Demonmerot (F)
L Millon (L)
F Bruschi (F)
G Calleri (G)
C Chemla (C)
B Castiglioni (B)
L G Chianura (LG)
B Dezsényi (B)
M F Harandi (MF)
S Nasibi (S)
G Ismailova (G)
M T Giordani (MT)
V Gjoni (V)
R Shkjezi (R)
L Gogichaishvili (L)
D Goletti (D)
F Karim (F)
E Lapini (E)
S Mastrandrea (S)
F Lötsch (F)
G Menozzi (G)
R Corsini (R)
P Milhailescu (P)
S Orsten (S)
A Paugam (A)
M Ramharter (M)
A Recordare (A)
F Salvador (F)
A Teggi (A)
C Torti (C)
G Vitale (G)
A Vola (A)
M Mariconti (M)
R Lissandrin (R)
M Wallon (M)
L Zammarchi (L)
F Bartalesi (F)

Références

PLoS Negl Trop Dis. 2016 Aug 22;10(8):e0004942
pubmed: 27547975
Adv Parasitol. 2017;95:315-493
pubmed: 28131365
Acta Trop. 2014 Dec;140:91-6
pubmed: 25149351
Clin Infect Dis. 2015 Mar 1;60(5):721-8
pubmed: 25422388
Parasitol Res. 2016 Nov;115(11):4261-4265
pubmed: 27473835
Curr Opin Infect Dis. 2014 Oct;27(5):425-31
pubmed: 25101556
Acta Trop. 2010 Apr;114(1):1-16
pubmed: 19931502
Eur J Epidemiol. 2019 Jun;34(6):611-612
pubmed: 30739267
Trends Parasitol. 2019 Aug;35(8):663-664
pubmed: 31182386
PLoS Negl Trop Dis. 2016 Dec 19;10(12):e0005243
pubmed: 27992434
PLoS Negl Trop Dis. 2012;6(11):e1915
pubmed: 23209857
Lancet Infect Dis. 2018 Jul;18(7):769-778
pubmed: 29793823
Am J Trop Med Hyg. 2016 Aug 3;95(2):405-9
pubmed: 27273641
Am J Trop Med Hyg. 2018 Aug;99(2):375-379
pubmed: 29869600
Emerg Infect Dis. 2006 Feb;12(2):296-303
pubmed: 16494758
PLoS Negl Trop Dis. 2017 Jul 26;11(7):e0005771
pubmed: 28746395
Parasit Vectors. 2016 Apr 28;9:243
pubmed: 27126135
Euro Surveill. 2015 May 07;20(18):
pubmed: 25990235

Auteurs

Patrizia Rossi (P)

European Reference Laboratory for Parasites, Department of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy.
WHO Collaborating Centre for the Epidemiology, Detection and Control of Cystic and Alveolar Echinococcosis, Department of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy.

Francesca Tamarozzi (F)

European Reference Laboratory for Parasites, Department of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy.
WHO Collaborating Centre for the Epidemiology, Detection and Control of Cystic and Alveolar Echinococcosis, Department of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy.

Fabio Galati (F)

DG-INF - Information Technology Service, Istituto Superiore di Sanità, Rome, Italy.

Okan Akhan (O)

Department of Radiology, Faculty of Medicine, Hacettepe University, Ankara, Turkey.

Carmen Michaela Cretu (CM)

C. Davila University of Medicine and Pharmacy, Colentina Clinical Hospital, Bucharest, Romania.

Kamenna Vutova (K)

Specialised Hospital of Infectious and Parasitic Diseases "Prof. Ivan Kirov", Department of Infectious, Parasitic and Tropical Diseases, Medical University, Sofia, Bulgaria.

Mar Siles-Lucas (M)

Instituto de Recursos Naturales y Agrobiología de Salamanca, CSIC, Salamanca, Spain.

Enrico Brunetti (E)

Department of Clinical Surgical Diagnostic and Paediatric Sciences, University of Pavia, Pavia, Italy.
Division of Tropical and Infectious Diseases, San Matteo Hospital Foundation, Pavia, Italy.

Adriano Casulli (A)

European Reference Laboratory for Parasites, Department of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy. adriano.casulli@iss.it.
WHO Collaborating Centre for the Epidemiology, Detection and Control of Cystic and Alveolar Echinococcosis, Department of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy. adriano.casulli@iss.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH